dm+d
420306005
Articles
Safety in lactation: Drugs for chronic bowel disorders
21 September 2020
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…Lactation Safety Information
-
No published evidence of safety
Mesalazine, of which balsalazide is the active metabolite, has been associated with a small number of possible cases of diarrhoea in breastfed infants
Monitor infant for diarrhoea
4 August 2020